OUR SCIENCE

Our science is pioneering the development of MotionTx platform, a new modality of therapeutic entities with unique properties to penetrate tissues and accumulate in target cells. 

MOTION TX PLATFORM

New Modality

Novel class of therapies with unique tissue penetration capabilities

Platform Technology

Can carry a variety of drugs for different therapeutic indications

Targeted Delivery

Maximizing local routes of administration

PLATFORM
MotionTx Platform will benefit patients by improving the accumulation of therapeutic drugs in target cells.

PLATFORM

MotionTx Platform will benefit patients by improving the accumulation of therapeutic drugs in target cells.

NBT-101

Bladder Cancer

NBT-102

Undisclosed indication